This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

AC0010MA

ACEA Biosciences Inc.

Drug Names(s): AC 0010MA, AC0010, AC 0010

Description: AC0010MA is an orally available selective inhibitor of mutant forms of the epidermal growth factor receptor (EGFR), including the second-site resistance mutation T790M, with potential antineoplastic activity for the treatment of non-small cell lung cancer. AC0010MA specifically and irreversibly binds to and inhibits the activity of mutant forms of EGFR, preventing EGFR mutant-mediated signaling and leads to cell death in EGFR mutant-expressing tumor cells.


AC0010MA News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug